CN111419982A - 一种治疗强直性脊柱炎的中药组合物 - Google Patents
一种治疗强直性脊柱炎的中药组合物 Download PDFInfo
- Publication number
- CN111419982A CN111419982A CN202010416543.7A CN202010416543A CN111419982A CN 111419982 A CN111419982 A CN 111419982A CN 202010416543 A CN202010416543 A CN 202010416543A CN 111419982 A CN111419982 A CN 111419982A
- Authority
- CN
- China
- Prior art keywords
- parts
- ankylosing spondylitis
- traditional chinese
- chinese medicine
- treating ankylosing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 31
- 206010002556 Ankylosing Spondylitis Diseases 0.000 title claims abstract description 24
- 239000000203 mixture Substances 0.000 title claims description 11
- 210000003734 kidney Anatomy 0.000 claims abstract description 25
- 235000018735 Sambucus canadensis Nutrition 0.000 claims abstract description 9
- 235000007123 blue elder Nutrition 0.000 claims abstract description 9
- 235000007124 elderberry Nutrition 0.000 claims abstract description 9
- 235000008995 european elder Nutrition 0.000 claims abstract description 9
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 7
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 7
- 229940079593 drug Drugs 0.000 claims abstract description 7
- 235000008434 ginseng Nutrition 0.000 claims abstract description 7
- 241000287828 Gallus gallus Species 0.000 claims abstract description 6
- 235000013250 Viburnum opulus var sargentii Nutrition 0.000 claims abstract description 6
- 240000004861 Viburnum opulus var. sargentii Species 0.000 claims abstract description 6
- 244000237330 gutta percha tree Species 0.000 claims abstract description 6
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 240000005779 Jasminum multiflorum Species 0.000 claims abstract description 5
- 241000195954 Lycopodium clavatum Species 0.000 claims abstract description 5
- 241000208829 Sambucus Species 0.000 claims description 8
- 241000208340 Araliaceae Species 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 244000151637 Sambucus canadensis Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 18
- 208000006820 Arthralgia Diseases 0.000 description 15
- 210000000988 bone and bone Anatomy 0.000 description 13
- 210000001624 hip Anatomy 0.000 description 12
- 210000004185 liver Anatomy 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 9
- 238000005728 strengthening Methods 0.000 description 9
- 230000001717 pathogenic effect Effects 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 210000002435 tendon Anatomy 0.000 description 6
- 208000008035 Back Pain Diseases 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 210000003127 knee Anatomy 0.000 description 5
- 241000208688 Eucommia Species 0.000 description 4
- 208000008930 Low Back Pain Diseases 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 210000001503 joint Anatomy 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 208000025747 Rheumatic disease Diseases 0.000 description 3
- 206010042674 Swelling Diseases 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000037182 bone density Effects 0.000 description 3
- 230000009545 invasion Effects 0.000 description 3
- 210000000963 osteoblast Anatomy 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 230000000552 rheumatic effect Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical group [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010023232 Joint swelling Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 201000002661 Spondylitis Diseases 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 210000000845 cartilage Anatomy 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000001969 hypertrophic effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 210000005067 joint tissue Anatomy 0.000 description 2
- 208000024765 knee pain Diseases 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 201000003068 rheumatic fever Diseases 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- INYYVPJSBIVGPH-UHFFFAOYSA-N 14-episinomenine Natural products C1CN(C)C2CC3=CC=C(OC)C(O)=C3C31C2C=C(OC)C(=O)C3 INYYVPJSBIVGPH-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 235000011202 Angiopteris lygodiifolia Nutrition 0.000 description 1
- 208000008822 Ankylosis Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 241001148495 Cibotium barometz Species 0.000 description 1
- 244000241463 Cullen corylifolium Species 0.000 description 1
- 241000723185 Cyathea Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010023198 Joint ankylosis Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000006735 Periostitis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241001446509 Psoralea Species 0.000 description 1
- INYYVPJSBIVGPH-QHRIQVFBSA-N Sinomenine Chemical compound C([C@@H]1N(CC2)C)C3=CC=C(OC)C(O)=C3[C@@]32[C@@H]1C=C(OC)C(=O)C3 INYYVPJSBIVGPH-QHRIQVFBSA-N 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000002223 anti-pathogen Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- RARWEROUOQPTCJ-RBUKOAKNSA-N cepharamine Natural products C1CC2=CC=C(OC)C(O)=C2[C@@]2(CCN3C)[C@]13C=C(OC)C(=O)C2 RARWEROUOQPTCJ-RBUKOAKNSA-N 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 210000004394 hip joint Anatomy 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- DJGAAPFSPWAYTJ-UHFFFAOYSA-M metamizole sodium Chemical compound [Na+].O=C1C(N(CS([O-])(=O)=O)C)=C(C)N(C)N1C1=CC=CC=C1 DJGAAPFSPWAYTJ-UHFFFAOYSA-M 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 210000003460 periosteum Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 210000001369 pituitary-adrenal system Anatomy 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 229930002966 sinomenine Natural products 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/487—Psoralea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种治疗强直性脊柱炎的中药,是由下列重量份的原料药组成:马尾伸筋草3~6重量份;狗脊、补骨脂、络石藤、青风藤、南方荚蒾7~15重量份;杜仲9~18重量份;鸡肾参、接骨木15~30重量份。
Description
技术领域
本发明属于中药技术领域,尤其是涉及一种治疗强直性脊柱炎的中药组合物。
背景技术
强直性脊柱炎是一种主要侵犯脊柱,并累及骶髂关节和周围关节的慢性进行性炎性疾病。它是一种具有家族倾向的、致残性的风湿病,好发于青少年男性,男女比例7~10:1。强直性脊柱炎发病早期,病人只感腰、背疼痛,严重者脊柱功能活动受限;中期腰背、下肢关节疼痛较显着,脊柱功能活动受限,甚至部分强直,此时如能及时诊断和正确治疗大多可获良好效果;晚期炎症已基本消失,关节无疼痛,而以脊柱固定和强直为主要表现。颈椎固定性前倾,脊柱后凸,胸廓常固定在呼气状态,腰椎生理弯曲丧失,髋关节和膝关节严重屈曲挛缩,站立时双目凝视地面,身体重心前移。个别病人可严重致残,长期卧床,生活不能自理。目前,没有治疗强直性脊柱炎的特效药,西医采用激素、止疼药物治疗,只能缓解疼痛,不能治愈。
发明内容
本发明的目的在于改进已有技术的不足而提供一种治疗强直性脊柱炎的中药组合物,可以有效地改善甚至消除患者的临床症状,具有治疗效果显著、治疗周期短、无毒副作用等特点。
中医将强直性脊柱炎归属于痹症之“骨痹”、“肾痹”、“妊痹”范畴。正气不足,督脉失养,是强直性脊柱炎发病的内因。它是自身免疫性疾病,患者身体存在的一种抗原体,破坏了免疫系统,使得患者身体免疫力减弱。因此,应滋补肝肾、强筋骨、壮腰脊、温肾助阳、活血消肿、扶正固本,增强免疫力,促使身体关节组织再生活性细胞及正常骨关节细胞,促进软骨组织修复,增加骨密度,平衡身体新陈代谢,抗击病原体的再次入侵。
外因是外感六淫诸邪。正气不足,风寒湿邪入侵,阻滞经络,血脉阻塞,关节凝滞,使气血运行不畅,而成痹病。风寒湿痹可逐渐化热形成寒热错杂痹,甚至可以完全转化为热痹。因此,祛风湿,通经络,利关节,理气止痛,直接歼灭淤积在脊柱及关节部位的抗原体并彻底清除体外。
基于上述理论,本发明提供了一种治疗强直性脊柱炎的中药,由下列重量份的原料药组成:马尾伸筋草3~6重量份;狗脊、补骨脂、络石藤、青风藤、南方荚蒾7~15重量份;杜仲9~18重量份;鸡肾参、接骨木15~30重量份。
在一个优选的实施方案中,所述治疗强直性脊柱炎的中药组合物由下列重量份的原料药组成:马尾伸筋草6重量份;狗脊、补骨脂、络石藤、青风藤、南方荚蒾15重量份;杜仲18重量份;鸡肾参、接骨木30重量份。
其中,补骨脂:辛、苦,温。归肾、脾经。补肾助阳,温脾止泻,纳气,增强免疫力。用于命门火衰,下元虚冷之腰膝冷痛,脾肾两虚,补骨脂有壮骨作用,可有效抑制骨的吸收且不抑制骨的形成。可以增加皮质厚度和小梁骨的骨矿含量,因此增加骨密度和骨的负荷强度。
狗脊:苦、甘,温。归肝、肾经。具有补肝肾,强腰脊,祛风湿,利关节、固肾气的功效。用于腰膝酸软,下肢无力,风湿痹痛,治疗风湿性关节炎,尤以风湿性腰脊痛疗效更佳。《神农本草经》云其“主腰背强,关机缓急、周痹、寒湿膝痛。”《别录》谓:“坚脊、利俛仰、女子伤中、关节重。”
南方荚蒾:味苦;涩;性凉。疏风解表;活血散冷冻;清热解毒。用于肥大性脊椎炎,风湿痹痛等。
马尾伸筋草:味淡、平。祛风除湿,舒筋活络。用于风湿关节痛,类风湿性关节炎,肥大性脊椎炎。
杜仲:甘,温。归肝、肾经。具有补肝肾,强筋骨,祛风湿,镇痛及抗炎功效。《神农本草经》云:“主腰脊痛,补中益精气,坚筋骨,强志,除阴下痒湿,小便余沥。”能促进骨髓质细胞增殖和成骨细胞分化,直接促进成骨细胞增殖。
狗脊配杜仲配伍发挥协同作用,共奏补益肝肾、强腰膝、壮筋骨之功,因“督为肾之外垣”(《本草逢原》),肾气内充,则外垣得固,故二药配伍还有补肾益督之功用。且因二药性质平和,随证配伍可应用于强直性脊柱炎各期。
狗脊与杜仲、补骨脂:狗脊祛风湿、强腰键脚。杜仲补肾益肝,强腰脚而祛风湿。补骨脂温补肾阳。三者合用治疗腰膝虚寒冷痛、足膝无力及类风湿性关节炎等症。
鸡肾参:味甘;微辛;温。归肾经。补肾强腰;理气止痛。用于肾虚腰痛等。
络石藤:苦;辛;性微寒。归心;肝;肾经。通络消肿;凉血止痛;清热解毒。用于腰膝酸痛;风湿热痹,筋脉拘挛等,治疗风湿热痹祛风清热,解毒消肿,效果更好。络石藤有显著地利关节止疼痛,舒筋脉,止拘挛作用,对强直性脊柱炎中期有显著疗效。
青风藤:味苦、辛,平。归肝、脾经。祛风湿,通经络,利小便。用于风湿痹痛,关节肿胀,麻痹瘙痒。青藤碱能降低肾上腺内维生素C的含量,通过下丘脑影响垂体-肾上腺系统而显著消退关节炎。对晨僵有显著疗效,可用于强直性脊柱炎急性期,。
接骨木:甘、苦,平。归肝经。接骨续筋,活血止痛,祛风利湿。用于骨折,跌打损伤,风湿性关节炎,大骨节病。接骨木促进成骨细胞增殖及分化;促进细胞碱性磷酸酶活性。明显促进骨痂形成和钙、磷骨折部位沉积。有镇痛作用,作用强度次于吗啡,优于安乃近。
本发明中杜仲、狗脊、补骨脂、接骨木能够提升患者身体免疫力,平衡身体新陈代谢,抗击病原体的再次入侵。杜仲、鸡肾参、补骨脂、接骨木促使身体关节组织再生活性细胞及正常骨关节细胞,促进软骨组织修复,增加骨密度;狗脊、络石藤、青风藤、南方荚蒾、马尾伸筋草祛风除湿,能够直接歼灭淤积在脊柱及关节部位的抗原体并彻底清除体外;诸药配合能从根本上修复骨膜膜囊,让受损组织迅速再生,消除关节肿胀、麻木、僵直、屈伸不利等症状,使整体机能得到再生和恢复,从整体上来调节人的机体,以达到到一个新的平衡态,从而达到彻底治愈的目的。
本发明是由中国传统的中草药制成,根据中医辨证论治及现代医学的若干原则,以某些成分确定、功效明晰的天然提取物的有序配伍,组合成了有效治疗强直性脊柱炎的中药。
本发明可以贯穿于强直性脊柱炎治疗的全过程,标本兼治,不易复发,安全可靠,无明显毒副反应,便于患者长期坚持服用,用药多年来,患者无任何不良反应,跟踪血液检查正常。
本发明的中药组合物原料易得,工艺简单,成本低,效率高,有利于制药企业进行药品生产、质量控制;产品价格低,易于被患者接受。
本发明的中药组合物治疗早期、中期强直性脊柱炎效果显著,临床实验结果显示,用本药方施治,每日一剂,水煎100-150ml,分成两份,早晚各一份服用,以一个月为一疗程,一般一个疗程见效,三个疗程可见明显改善,六个疗程功能基本痊愈。6个疗程治愈率86%,显效率为95%,总有效率为100%。
本发明还提供了一种由上述治疗强直性脊柱炎的中药组合物制成的口服制剂,所述口服制 剂包括口服液、片剂、胶囊剂、丸剂等,优选剂型为片剂和胶囊剂,一日一剂,分早晚两次服用。
本发明的中药组合物可以制备成多种剂型。例如,将煎煮后的药液杀菌消毒后装袋,制成口服液;或者将煎煮后的药液进行浓缩,烘干后,加入医学上可接收的辅料,然后制成片剂、胶囊剂、丸剂等。
所述医学上可接收的辅料包括淀粉、糊精、羧甲基纤维素钠、聚乙二醇、磷酸氢钙、海藻酸钠、山梨酸钾等。
以上所述,仅是本发明的较佳实施例而已,并非对本发明作任何形式上的限制,本领域技术人员利用上述揭示的技术内容做出些许简单修改、等同变化或修饰,均落在本发明的保护范围内。
Claims (4)
1.一种治疗强直性脊柱炎的中药,其特征是由下列重量份的原料药组成:马尾伸筋草3~6重量份;狗脊、补骨脂、络石藤、青风藤、南方荚蒾7~15重量份;杜仲9~18重量份;鸡肾参、接骨木15~30重量份。
2.根据权利要求1所述的一种治疗强直性脊柱炎的中药,其特征是由下列重量份的原料药组成:马尾伸筋草6重量份;狗脊、补骨脂、络石藤、青风藤、南方荚蒾15重量份;杜仲18重量份;鸡肾参、接骨木30重量份。
3.一种治疗强直性脊柱炎的口服制剂,其特征是由权利要求1或2中任一项所述的中药组合物制成。
4.根据权利要求3所述的一种治疗强直性脊柱炎的口服制剂,其特征是包括口服液、片剂、胶囊剂、丸剂,优选口服液和片剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010416543.7A CN111419982A (zh) | 2020-05-18 | 2020-05-18 | 一种治疗强直性脊柱炎的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010416543.7A CN111419982A (zh) | 2020-05-18 | 2020-05-18 | 一种治疗强直性脊柱炎的中药组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111419982A true CN111419982A (zh) | 2020-07-17 |
Family
ID=71550959
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010416543.7A Pending CN111419982A (zh) | 2020-05-18 | 2020-05-18 | 一种治疗强直性脊柱炎的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111419982A (zh) |
-
2020
- 2020-05-18 CN CN202010416543.7A patent/CN111419982A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102284028B (zh) | 一种治疗类风湿关节炎的药物 | |
CN103349753B (zh) | 一种治疗肾虚的中药组合物 | |
CN103505659A (zh) | 一种治疗类风湿关节炎的中成药 | |
CN100528194C (zh) | 治疗股骨头坏死的药物 | |
CN1970045B (zh) | 一种治疗颈腰椎病的外用中药 | |
CN101199721B (zh) | 治疗股骨头坏死的中药丸 | |
CN106237266B (zh) | 一种治疗腰椎间盘突出症的温养督脉中药组合物 | |
CN114053354A (zh) | 益肾壮骨的中药组合物及其制备方法和应用 | |
CN111419982A (zh) | 一种治疗强直性脊柱炎的中药组合物 | |
CN106362066A (zh) | 一种治疗风湿类风湿性疾病的药酒及其制备方法 | |
CN103191315B (zh) | 一种治疗绝经后骨质疏松症的中药 | |
CN102145099A (zh) | 治疗肝郁不孕的中药 | |
CN100363036C (zh) | 治疗骨缺血坏死、骨折迟缓愈合及骨不连的药物 | |
CN104161805A (zh) | 一种治疗股骨头坏死的中药及制备方法 | |
AU2021101824A4 (en) | Zhuang Medicine Compound Moxa Stick for Treating Ankylosing Spondylitis and Preparation Method Thereof | |
CN102100797A (zh) | 治疗脊椎结核病的中药制剂 | |
CN1246022C (zh) | 接骨散 | |
CN111658728A (zh) | 一种治疗痹症的中药组合物 | |
CN105169054A (zh) | 一种治疗急慢性骨关节炎的中药制剂及其制备方法 | |
CN105213793A (zh) | 主治骨质疏松的中药组合物及制法 | |
CN104587205B (zh) | 一种治疗骨折的药物 | |
CN114652797A (zh) | 用于骨折患者养血补气的中药配方及其中药液的制备方法 | |
CN113209200A (zh) | 一种治疗痹症的中药组合物 | |
CN109985136A (zh) | 治疗股骨头坏死的中药组合物 | |
CN111905056A (zh) | 一种治疗风湿、类风湿及各种骨病的中药组方 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200717 |